Shares of Acadia Pharmaceuticals Inc. ACAD have risen 14.9% in the past three months against the industry’s decrease of 8.4%.

In a report released today, Uy Ear from Mizuho Securities maintained a Hold rating on ACADIA Pharmaceuticals (ACAD – Research Report), with a price target of $19.00.

Raymond James analyst Danielle Brill maintained a Hold rating on ACADIA Pharmaceuticals (ACAD – Research Report) yesterday. The company’s shares closed yesterday at $19.40. According to ...

If you like to be creative and you’re a fan of the Greene County Fair you might have the opportunity to attend this year’s fair for free – every day!

The Cleveland Browns have unveiled some tweaks to its logo and colors for 2015. According to the Browns' website, the design will push to the future while honoring the past. "Our updated helmet ...

THE Hells Angels claim their feelings have been hurt, and they are “distressed” by their fearsome bikie logo appearing on hipster T-shirts and have called in the lawyers.

Shares of Acadia Pharmaceuticals Inc. ACAD have plunged 33.5% in the past three months compared with the industry’s decrease of 7.6%.